MDFA and TerryWhite Chemmart are providing people aged 50+ with a fast, easy way to understand and assess their general risk factors for macular disease.
Read MoreMDFA and TerryWhite Chemmart are providing people aged 50+ with a fast, easy way to understand and assess their general risk factors for macular disease.
Read MoreThe centenarian, whose bookshelves and cupboards are crammed with biographies, literary classics and the odd Agatha Christie mystery, regards her regular eye injections as a lifeline.
Read MoreSince 2001, MDFA has supported thousands of people each year with information about macular disease.
Read MoreInherited retinal diseases (IRDs) have a significant impact on the Australian population, with approximately 1
Read MoreMDFA’s latest newsletter is out now.
Read MoreMDFA is Australia’s largest source of research funding in the field of macular disease outside of government.
Read MoreComposition and functionality of high-density lipoprotein in age-related macular degeneration and a high-risk disease phenotype
Read MoreRedefining macular disease diagnosis to improve access to emerging therapies
Read More